Aggressive lifestyle and risk factor control after ablation significantly lowers atrial fibrillation recurrence and improves ...

Panelists discuss how new dual-targeting agents and TKIs are redefining treatment approaches in EGFR-positive NSCLC.

Rocatinlimab shows real-world promise for moderate to severe AD, enhancing treatment efficacy and reducing steroid reliance, explains Emma Guttman-Yassky, MD, PhD.

Changing the FDA biosimilar interchangeability standards is a necessary but likely insufficient step to improve biosimilar competition in the US.

Arkansas House Bill 1150 aims to protect independent pharmacies but may limit patient access and conflict with federal laws.

The study showed that hair loss disorders generally lead to impaired QOL, with psychological well-being being the most affected domain. The mean (SD) DLQI score for all participants was 7.86 (6.59), ...

This analysis reviews the history and current status of biosimilar regulation in the US, concluding that changing the FDA’s interchangeability standards—as proposed by some policy makers—is a ...

ACA marketplace premiums are projected to rise by 26% in 2026, with potential further increases if premium tax credits expire ...

Increasing respiratory syncytial virus (RSV) vaccination among older adults could prevent up to 1600 deaths and 20,000 ...

Over the past generation, advances in treating common cancers—breast, lung, melanoma, and gastrointestinal (GI)—have improved ...

Brigid Groves, PharmD, MS, discusses the importance of using trustworthy sources so that pharmacists can support communities ...

It is necessary to balance rigorous clinical trials with real-world evidence (RWE) to show how data from everyday practice ...